Drug Type CAR-T |
Synonyms- |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Adze Biotechnology, Inc.Startup |
Active Organization Adze Biotechnology, Inc.Startup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Melanoma | Preclinical | US | Adze Biotechnology, Inc.Startup | 10 Oct 2023 |
Non-Small Cell Lung Cancer | Preclinical | US | Adze Biotechnology, Inc.Startup | 10 Oct 2023 |
Pancreatic Cancer | Preclinical | US | Adze Biotechnology, Inc.Startup | 10 Oct 2023 |
Prostatic Cancer | Preclinical | US | Adze Biotechnology, Inc.Startup | 10 Oct 2023 |
Squamous Cell Carcinoma of Head and Neck | Preclinical | US | Adze Biotechnology, Inc.Startup | 10 Oct 2023 |